{{Rsnum
|rsid=6585194
|Gene=TCF7L2
|Chromosome=10
|position=114717471
|Orientation=plus
|GMAF=0.3613
|Gene_s=TCF7L2
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 52.3 | 40.0 | 7.7
| HCB | 33.3 | 48.9 | 17.8
| JPT | 36.4 | 50.0 | 13.6
| YRI | 14.3 | 54.0 | 31.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 33.3 | 48.9 | 17.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23558246
|Title=Impacts of TCF7L2 gene polymorphisms on the susceptibility of hepatogenous diabetes and hepatocellular carcinoma in cirrhotic patients
}}{{PMID Auto
|PMID=19351735
|Title=Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.
|OA=1
}}